Navigation Links
Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma
Date:5/20/2008

Lawson, M.D., Emory University School of Medicine. "Identifying novel therapies like elesclomol represent the future of treating this hard-to-treat disease."

Data for patients on the elesclomol and paclitaxel arm who had one prior chemotherapy showed a trend toward results similar to patients who had received no prior chemotherapy; however these data were not statistically significant. Specifically, after receiving one prior chemotherapy, the median PFS was 2.8 months for patients receiving elesclomol and paclitaxel (n=29) versus 1.8 months for patients on paclitaxel alone (n=20; p=0.552), and OS was 9.0 months for patients on elesclomol and paclitaxel versus 7.8 months for patients on paclitaxel alone.(1)

Regardless of prior chemotherapy, the most common adverse events in the elesclomol plus paclitaxel group included fatigue, alopecia, constipation, nausea, hypoaesthesia, arthralgia, insomnia, diarrhea and anemia. The most serious adverse events (Grade 3 or higher) for the combination arm were similar to those seen in the paclitaxel-only arm and included neutropenia, back pain, fatigue and neuropathy.(1)

About Elesclomol

Elesclomol is a novel, injectable, investigational drug candidate that triggers apoptosis (programmed cell death) in cancer cells. Cancer cells operate at high levels of reactive oxygen species, or oxidative stress. Elesclomol is believed to act by increasing the level of oxidative stress in cancer cells even further, beyond sustainable levels, inducing apoptosis. This mechanism of action, called oxidative stress induction, represents a novel way of selectively targeting and killing cancer cells.

Elesclomol is being developed under a global collaboration agreement between Synta Pharmaceuticals and GlaxoSmithKline.

Ongoing Clinical Trials

GlaxoSmithKline and Synta Pharmaceuticals are currently studying elesclomol in a global, pivotal Phase III trial called SYMMETRY(SM). The SYMMETRY study is being con
'/>"/>

SOURCE GlaxoSmithKline; Synta Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
2. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
3. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
4. Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol
5. Amikacin Inhale Shows Promising Results in Phase II Study
6. Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
7. Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
8. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
9. Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
10. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
11. Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... Spain , July 4, 2015 ... first-line chemotherapy for patients with unresectable metastatic colorectal ... Survival in that organ Patients with ... only to the liver experienced the greatest improvement ... the addition of SIR-Spheres Y-90 resin microspheres to ...
(Date:7/3/2015)... According to a new ... Management Market ECG, Implantable Loop Recorder, Manual Event ... Dual Chamber Pacemaker, CRT-D, CRT-P - Global Forecast ... Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices ... 2020 from $21,137.7 Million in 2015, at a ...
(Date:7/3/2015)... Der Pharmariese Lupin ... eine 100-prozentige Beteiligung am Unternehmen ZAO "Biocom" ... Übernahme dringt Lupin in den russischen Pharmamarkt ... Mrd. RUB im Jahr 2014 zu den ... Health). Seit über einem Jahrzehnt verzeichnet der ...
Breaking Medicine Technology:New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3
... July 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, ... Dr. Shizuko Sei et al. published the results of ... cell lung cancer (NSCLC). The paper, entitled "Synergistic Antitumor ... Cell Lung Cancer Cells" appears online in the July ...
... LEXINGTON, Massachusetts, July 16 Shire plc,(LSE: SHP, NASDAQ: ... received Fast Track designation from the U.S. Food and Drug,Administration ... the treatment of Type I Gaucher disease. Shire is working,with ... filing of its,NDA. , Fast Track ...
Cached Medicine Technology:Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC 2Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 2Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 3Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4
(Date:7/6/2015)... ... ... With a new community program in the Livonia, Canton and Plymouth areas, ... new charity campaign to raise funds in support of the health and safety of ... Youth is a coalition created especially to educate and empower teens, bringing awareness to ...
(Date:7/6/2015)... Pompano Beach, Florida (PRWEB) , ... July 06, ... ... call center solutions, announced today that Randstad Technologies selected Aspect Software Unified IP ... provider in the United States, selected Aspect Unified IP as its future call ...
(Date:7/6/2015)... Texas (PRWEB) , ... July 06, 2015 , ... The ... thought-provoking look into the economic transformation associated with the U.S. economy over the past ... consequences associated with its use. In many ways, the book is a time capsule ...
(Date:7/5/2015)... ... July 05, 2015 , ... ... the Weed Master, a landscaping invention that effectively removes weeds without harming ... dollars," says Scott Cooper, CEO and Creative Director of World Patent Marketing. "It ...
(Date:7/4/2015)... ... July 04, 2015 , ... ... published the results of an annual member survey , detailing the most ... More recently, the group broke that raw data down into charts detailing demographic ...
Breaking Medicine News(10 mins):Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 2Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 3Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3
... cardiac function in aging mice, scientists report , MONDAY, ... age-related deterioration in the hearts of mice by suppressing ... system that helps regulate the life span of cells, ... the control of heart failure in humans. , "A ...
... of treatment, experts suggest , MONDAY, Oct. 12 ... estrogen/progestin hormone replacement therapy could signal increased chances ... , Women taking estrogen plus progestin who reported ... were 48 percent more likely to develop invasive ...
... ... additional New York counties - Washington, Warren, and Essex - to complement its growing service ... PPO plans, effective January 1, 2010. , ... Albany, N.Y. (Vocus) October 12, 2009 -- CDPHP announced the ...
... , OAKLAND, Calif., Oct. 12 Kaiser Permanente has ... Care Award" by the National Committee for Quality Assurance ... to provide health plan members with care that meets ... improve care for its culturally diverse members is a ...
... CARROLLTON, Ga., Oct. 12 , -- The Health ... a key step in the development of a national and ... industry , -- Americans seek care from more than 600,000 ... The majority of these physicians, however, cannot efficiently exchange patient ...
... SAN FRANCISCO, Oct. 7 Within3 , ... and life sciences institutions, today announced that the American College ... extend its Annual Scientific Meeting to a year-round forum by ... , ACG will launch the ACG GI ...
Cached Medicine News:Health News:A Gene Tweak Could Keep Heart Young 2Health News:A Gene Tweak Could Keep Heart Young 3Health News:With Hormone Therapy, Tender Breasts May Signal Cancer Risk 2Health News:With Hormone Therapy, Tender Breasts May Signal Cancer Risk 3Health News:CDPHP Medicare Choices Expands Service Area Northward 2Health News:CDPHP Medicare Choices Expands Service Area Northward 3Health News:Kaiser Permanente Recognized by National Committee for Quality Assurance for Innovative Efforts to Reduce Health Care Disparities 2Health News:Kaiser Permanente Recognized by National Committee for Quality Assurance for Innovative Efforts to Reduce Health Care Disparities 3Health News:Kaiser Permanente Recognized by National Committee for Quality Assurance for Innovative Efforts to Reduce Health Care Disparities 4Health News:Greenway Medical Technologies' EHR Platform Continues to Lead Interoperability Efforts With Participation in Key Health IT Integration Showcases 2Health News:Greenway Medical Technologies' EHR Platform Continues to Lead Interoperability Efforts With Participation in Key Health IT Integration Showcases 3Health News:Greenway Medical Technologies' EHR Platform Continues to Lead Interoperability Efforts With Participation in Key Health IT Integration Showcases 4Health News:Launch of First Year-Round Annual Scientific Medical Meeting Announced at Health 2.0 2
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Quatroloc Revision Hip System...
A stable revision design with extensive sizes...
Medicine Products: